Naturewise Biotech & Medicals (ROCO:4732) Debt-to-Equity : 0.01 (As of Jun. 2024)

Naturewise Biotech & Medicals Debt-to-Equity Chart

Naturewise Biotech & Medicals Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Debt-to-Equity		Get a 7-Day Free Trial					0.02	0.01	0.02	0.01	0.02

Naturewise Biotech & Medicals Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Equity	Get a 7-Day Free Trial															0.01	0.01	0.01	0.02	0.01

Competitive Comparison of Naturewise Biotech & Medicals's Debt-to-Equity

For the Biotechnology subindustry, Naturewise Biotech & Medicals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Naturewise Biotech & Medicals's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Naturewise Biotech & Medicals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Naturewise Biotech & Medicals's Debt-to-Equity falls into.

Naturewise Biotech & Medicals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Naturewise Biotech & Medicals's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Naturewise Biotech & Medicals's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naturewise Biotech & Medicals  (ROCO:4732) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Naturewise Biotech & Medicals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Naturewise Biotech & Medicals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Naturewise Biotech & Medicals Business Description